메뉴 건너뛰기




Volumn 8, Issue 1, 2015, Pages 102-108

Angioplasty of femoral-popliteal arteries with drug-coated balloons: 5-year follow-up of the THUNDER Trial

Author keywords

Angioplasty; Drug coated balloon; Femoral artery; Long term outcome; Paclitaxel; Peripheral arterial disease

Indexed keywords

PACLITAXEL; BIOMATERIAL; CARDIOVASCULAR AGENT;

EID: 84921404014     PISSN: 19368798     EISSN: 18767605     Source Type: Journal    
DOI: 10.1016/j.jcin.2014.07.023     Document Type: Article
Times cited : (252)

References (11)
  • 1
    • 39049086820 scopus 로고    scopus 로고
    • Local delivery of paclitaxel to inhibit restenosis during angioplasty of the leg
    • Tepe G, Zeller T, Albrecht T, et al. Local delivery of paclitaxel to inhibit restenosis during angioplasty of the leg. N Engl J Med 2008;358:689-99.
    • (2008) N Engl J Med , vol.358 , pp. 689-699
    • Tepe, G.1    Zeller, T.2    Albrecht, T.3
  • 2
    • 54049125687 scopus 로고    scopus 로고
    • Inhibition of restenosis in femoropopliteal arteries: Paclitaxel-coated versus uncoated balloon: Femoral paclitaxel randomized pilot trial
    • Werk M, Langner S, Reinkensmeier B, et al. Inhibition of restenosis in femoropopliteal arteries: paclitaxel-coated versus uncoated balloon: femoral paclitaxel randomized pilot trial. Circulation 2008;118:1358-65.
    • (2008) Circulation , vol.118 , pp. 1358-1365
    • Werk, M.1    Langner, S.2    Reinkensmeier, B.3
  • 3
    • 84871967062 scopus 로고    scopus 로고
    • Paclitaxel-coated balloons reduce restenosis after femoro-popliteal angioplasty: Evidence from the randomized PACIFIER trial
    • Werk M, Albrecht T, Meyer DR, et al. Paclitaxel-coated balloons reduce restenosis after femoro-popliteal angioplasty: evidence from the randomized PACIFIER trial. Circ Cardiovasc Interv 2012;5:831-40.
    • (2012) Circ Cardiovasc Interv , vol.5 , pp. 831-840
    • Werk, M.1    Albrecht, T.2    Meyer, D.R.3
  • 4
    • 84868381885 scopus 로고    scopus 로고
    • Lower limb multilevel treatment with drug-eluting balloons: 6-month results from the DEBELLUM randomized trial
    • Fanelli F, Cannavale A, Boatta E, et al. Lower limb multilevel treatment with drug-eluting balloons: 6-month results from the DEBELLUM randomized trial. J Endovasc Ther 2012;19:571-80.
    • (2012) J Endovasc Ther , vol.19 , pp. 571-580
    • Fanelli, F.1    Cannavale, A.2    Boatta, E.3
  • 5
    • 84892987217 scopus 로고    scopus 로고
    • The LEVANT I (Lutonix Paclitaxel-Coated Balloon for the Prevention of Femoropopliteal Restenosis) trial for femoropopliteal revascularization: First-in-human randomized trial of low-dose drug-coated balloon versus uncoated balloon angioplasty
    • Scheinert D, Duda S, Zeller T, et al. The LEVANT I (Lutonix Paclitaxel-Coated Balloon for the Prevention of Femoropopliteal Restenosis) trial for femoropopliteal revascularization: first-in-human randomized trial of low-dose drug-coated balloon versus uncoated balloon angioplasty. J Am Coll Cardiol Intv 2014;7:10-9.
    • (2014) J Am Coll Cardiol Intv , vol.7 , pp. 10-19
    • Scheinert, D.1    Duda, S.2    Zeller, T.3
  • 6
    • 84858786273 scopus 로고    scopus 로고
    • Clinical evaluation of a paclitaxel-eluting balloon for treatment of femoropopliteal arterial disease: 12-month results from a multicenter Italian registry
    • Micari A, Cioppa A, Vadalà G, et al. Clinical evaluation of a paclitaxel-eluting balloon for treatment of femoropopliteal arterial disease: 12-month results from a multicenter Italian registry. J Am Coll Cardiol Intv 2012;5:331-8.
    • (2012) J Am Coll Cardiol Intv , vol.5 , pp. 331-338
    • Micari, A.1    Cioppa, A.2    Vadalà, G.3
  • 7
    • 84864124985 scopus 로고    scopus 로고
    • Combined treatment of heavy calcified femoro-popliteal lesions using directional atherectomy and a paclitaxel coated balloon: One-year single centre clinical results
    • Cioppa A, Stabile E, Popusoi G, et al. Combined treatment of heavy calcified femoro-popliteal lesions using directional atherectomy and a paclitaxel coated balloon: one-year single centre clinical results. Cardiovasc Revasc Med 2012;13:219-23.
    • (2012) Cardiovasc Revasc Med , vol.13 , pp. 219-223
    • Cioppa, A.1    Stabile, E.2    Popusoi, G.3
  • 8
    • 84884182920 scopus 로고    scopus 로고
    • 2-year results of paclitaxel-eluting balloons for femoropopliteal artery disease: Evidence from a multicenter registry
    • Micari A, Cioppa A, Vadalà G, et al. 2-year results of paclitaxel-eluting balloons for femoropopliteal artery disease: evidence from a multicenter registry. J Am Coll Cardiol Intv 2013;6:282-9.
    • (2013) J Am Coll Cardiol Intv , vol.6 , pp. 282-289
    • Micari, A.1    Cioppa, A.2    Vadalà, G.3
  • 9
    • 84858770246 scopus 로고    scopus 로고
    • Long-term follow-up after treatment of coronary instent restenosis with a paclitaxel-coated balloon catheter
    • Scheller B, Clever YP, Kelsch B, et al. Long-term follow-up after treatment of coronary instent restenosis with a paclitaxel-coated balloon catheter. J Am Coll Cardiol Intv 2012;5:323-30.
    • (2012) J Am Coll Cardiol Intv , vol.5 , pp. 323-330
    • Scheller, B.1    Clever, Y.P.2    Kelsch, B.3
  • 10
  • 11
    • 79955614495 scopus 로고    scopus 로고
    • Plasma levels following application of paclitaxel-coated balloon catheters in patients with stenotic or occluded femoropopliteal arteries
    • Freyhardt P, Zeller T, Kröncke TJ, et al. Plasma levels following application of paclitaxel-coated balloon catheters in patients with stenotic or occluded femoropopliteal arteries. Rofo 2011;183:448-55.
    • (2011) Rofo , vol.183 , pp. 448-455
    • Freyhardt, P.1    Zeller, T.2    Kröncke, T.J.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.